Rac1 regulates sepsis-induced formation of platelet-derived microparticles and thrombin generation

Yongzhi Wang1, Lingtao Luo2, Matthias Mörgelin3

  • 1Department of Clinical Sciences, Malmö, Section for Surgery, Lund University, Sweden.

Insights

Rac-1 inhibition reduces platelet-derived microparticles and thrombin generation in abdominal sepsis. Targeting Rac1 activity offers a potential therapeutic strategy for sepsis-induced coagulopathy.

Area of Science:

  • Coagulation and Thrombosis
  • Sepsis Pathophysiology
  • Molecular Biology

Background:

  • Dysfunctional coagulation is a significant factor in sepsis outcomes.
  • Platelet-derived microparticles (PMPs) and thrombin generation (TG) play critical roles in sepsis-associated coagulopathy.

Purpose of the Study:

  • To investigate the role of Rac-1 in PMP formation and TG during abdominal sepsis.
  • To evaluate the therapeutic potential of Rac1 inhibition in a mouse model of abdominal sepsis.

Main Methods:

  • Cecal ligation and puncture (CLP) model in male C57BL/6 mice.
  • Quantification of PMPs using scanning electron microscopy and flow cytometry.
  • Assessment of TG via fluorimetric assay and ex vivo plasma analysis.

Main Results:

  • CLP increased Rac1 activity in platelets; inhibition with NSC23766 abolished this effect.
  • Sepsis reduced ex vivo TG capacity, which was restored by NSC23766 administration.
  • Elevated circulating PMPs in septic mice were significantly reduced by NSC23766 treatment.
  • NSC23766 inhibited PMP formation in activated platelets in vitro.

Conclusions:

  • Rac-1 plays a key role in regulating PMP formation and TG in abdominal sepsis.
  • Inhibition of Rac1 activity presents a promising therapeutic target for managing sepsis-induced coagulopathy.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.1K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.2K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.7K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K